Timing of Initiation of First-line Antiretroviral Therapy
Summary
- Advent of effective ART, known as HAART, strengthened the case for earlier treatment initiation throughout the late 1990s
- Problematic toxicity, adherence, and risk of drug resistance tempered this enthusiasm
- Current options for first-line ART are simpler, more effective, and less toxic than earlier therapies
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Initial Antiretroviral Therapy